MedPath

Comparison of rosavastatin and atorvastatin on insulin resistance

Phase 3
Conditions
Diabetes mellitus.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20140514017686N2
Lead Sponsor
Ghoum University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Having type 2 diabetes
low-density lipoprotein (LDL) serum level above 70

Exclusion Criteria

Having cardiovascular diseases
Obvious liver disease and chronic kidney failure
Uncontrolled diabetes
Very High blood pressure
Corticosteroid use

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Homeostatic Model Assessment for Insulin Resistance calculation formula (HOMA-IR).
Secondary Outcome Measures
NameTimeMethod
Fasting blood sugar. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Blood test.;Serum insulin levels. Timepoint: At the beginning of the study and 12 weeks later. Method of measurement: Blood test.
© Copyright 2025. All Rights Reserved by MedPath